Gastroenterology

  • Home
  • Gastroenterology
Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Conditions:   Deleterious BRCA1 Gene Mutation;   Deleterious BRCA2 Gene Mutation;   Loss of Heterozygosity;   Lung Non-Small Cell Squamous Carcinoma;   Recurrent Large Cell Lung Carcinoma;   Recurrent Lung Adenocarcinoma;   Recurrent Lung Non-Small Cell Carcinoma;   Recurrent Non-Squamous Non-Small Cell Lung Carcinoma;   Stage IV Lung Cancer AJCC v8;   Stage IVA Lung Cancer AJCC v8;   Stage IVB Lung Cancer AJCC v8
Intervention:   Drug: Rucaparib
Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
Recruiting
ClinicalTrials.gov: Gastroenterology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

February 20, 2019 / by / in
Prospective Collection of PillCam SB3 Videos and Raw Data Files With Abnormal Findings for Future Developments (SODA)

Conditions:   Small Intestine Disease;   Small Intestine Cancer;   Small Intestinal Ulcer Bleeding;   Small Intestine Obstruction;   Small Intestine Adenocarcinoma;   Small Intestine Polyp
Intervention:  
Sponsor:   Medtronic – MITG
Recruiting
ClinicalTrials.gov: Gastroenterology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

February 15, 2019 / by / in
Ibrutinib and Obinutuzumab With or Without Venetoclax in Treating Older Patients With Untreated Chronic Lymphocytic Leukemia

Condition:   Chronic Lymphocytic Leukemia
Interventions:   Drug: Ibrutinib;   Biological: Obinutuzumab;   Other: Observation;   Drug: Venetoclax
Sponsor:   National Cancer Institute (NCI)
Recruiting
ClinicalTrials.gov: Gastroenterology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

January 14, 2019 / by / in
Somatosensory Profiles in Individuals With Persistent Musculoskeletal Pain and Inflammatory Bowel Disease

Conditions:   Inflammatory Bowel Diseases;   Chronic Pain;   Central Sensitization
Intervention:  
Sponsors:   Dartmouth-Hitchcock Medical Center;   University of Otago
Not yet recruiting
ClinicalTrials.gov: Gastroenterology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

January 11, 2019 / by / in